You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

folate

Showing 1 - 25 of 1,049
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Saint-Herblain (5-MTHF glucosamine salt, 5-MTHF calcium salt 1, 5-MTHF calcium salt 2)

Recruiting
  • Healthy
  • 5-MTHF glucosamine salt
  • +2 more
  • Saint-Herblain, France
    Biofortis
Jan 31, 2023

Epithelial Ovarian Cancer Trial in Leiden ([18F]fluoro-PEG-folate PET/CT scan)

Recruiting
  • Epithelial Ovarian Cancer
  • [18F]fluoro-PEG-folate PET/CT scan
  • Leiden, Zuid-holland, Netherlands
    Leiden University Medical Center
Aug 17, 2022

Rheumatoid Arthritis Trial (Natrunix with MTX (+folate), Natrunix with MTX (+folate))

Not yet recruiting
  • Rheumatoid Arthritis
  • Natrunix with MTX placebo (+folate)
  • Natrunix placebo with MTX (+folate)
  • (no location specified)
May 2, 2022

Neural Tube Defects, Folic Acid Deficiency, Fortification Trial in Birmingham (Salt with folic acid and iodine)

Active, not recruiting
  • Neural Tube Defects
  • +2 more
  • Salt with folic acid and iodine
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jul 6, 2023

Ovarian Cancer, Breast Cancer, Folic Acid Deficiency Trial in Chicago (Folic Acid Tablet)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Folic Acid Tablet
  • Chicago, Illinois
    Rush University Medical Center
Jul 17, 2022

Dietary Zinc Absorption Trial in Berkeley (Regular toast and juice, High phytate toast and juice, Regular toast and juice, with

Completed
  • Dietary Zinc Absorption
  • Regular toast and juice
  • +2 more
  • Berkeley, California
    University of California
Dec 19, 2022

Binge Drinking, Folate Deficiency Trial in Tulsa (Methyl Folate, Placebo)

Active, not recruiting
  • Binge Drinking
  • Folate Deficiency
  • Methyl Folate
  • Placebo
  • Tulsa, Oklahoma
    Oklahoma State University Center for Health Sciences
Apr 19, 2022

Endometrial Cancer Trial in New Haven (IMGN853)

Recruiting
  • Endometrial Cancer
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 10, 2022

Women's Health Food Frequency Questionnaire

Recruiting
  • Diet Habit
  • Questionnaire
  • Ankara, Turkey
  • +1 more
May 5, 2023

Ovarian Cancer Trial in Philadelphia (OTL38, intraoperative imaging camera system)

Withdrawn
  • Ovarian Cancer
  • OTL38
  • intraoperative imaging camera system
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 23, 2022

Skeletal Muscle Performance, Gene Polymorphisms Trial in Poznan (N-acetylcysteine, Placebo)

Recruiting
  • Skeletal Muscle Performance
  • Gene Polymorphisms
  • N-acetylcysteine
  • Placebo
  • Poznań, Poland
    Poznan University of Life Science
Nov 2, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Philadelphia (MOv19-BBz CAR T cells, Alpha Folate

Recruiting
  • Ovarian Cancer
  • +2 more
  • MOv19-BBz CAR T cells
  • Alpha Folate Receptor expression test
  • Philadelphia, Pennsylvania
    University of Pennsylvania Health System
Sep 12, 2022

Folate Trial in Toronto (Folic Acid supplementation, Adult Multivitamin)

Active, not recruiting
  • Folate
  • Folic Acid supplementation
  • Adult Multivitamin
  • Toronto, Ontario, Canada
    St. Michael's Hospital
Sep 1, 2021

Malnutrition Trial in Karachi (Iron folate tablets)

Completed
  • Malnutrition
  • Iron folate tablets
  • Karachi, Sind, Pakistan
    Aga Khan University karachi,pakistan
Aug 22, 2023

Osteosarcoma Trial in Seattle (SCRI-E2CAR_EGFRtv1, UB_TT170)

Recruiting
  • Osteosarcoma
  • Seattle, Washington
    Seattle Children's Hospital
May 31, 2022

Double-fortified Salt Containing Iodine and Folic Acid - Phase 1

Not yet recruiting
  • Folate Deficiency
  • +4 more
    • Addis Ababa, Ethiopia
      Ethiopian Public Health Institute
    Mar 30, 2023

    Gastric Intestinal Metaplasia Trial in Xi'an (Metformin, Folate)

    Recruiting
    • Gastric Intestinal Metaplasia
    • Xi'an, Shaanxi, China
    • +1 more
    Jan 29, 2023

    Pregnancy Trial in Vancouver (Folic acid, (6S)-5-methyltetrahydrofolic acid)

    Active, not recruiting
    • Pregnancy
    • Folic acid
    • (6S)-5-methyltetrahydrofolic acid
    • Vancouver, British Columbia, Canada
      University of British Columbia, Food Nutrition and Health Buildi
    Sep 22, 2021

    Breast Tumor, Neoplastic Cells, Circulating Trial in Handan (Peripheral blood sampling for circulating tumor cells)

    Active, not recruiting
    • Breast Neoplasm
    • Neoplastic Cells, Circulating
    • Peripheral blood sampling for circulating tumor cells
    • Handan, Hebei, China
      Kunwu Yan
    Jan 26, 2023

    Rheumatoid Arthritis Trial (Natrunix, Placebo)

    Not yet recruiting
    • Rheumatoid Arthritis
    • (no location specified)
    May 2, 2022

    Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in United States (STRO-002, Bevacizumab)

    Recruiting
    • Ovarian Cancer
    • +4 more
    • Tampa, Florida
    • +5 more
    Aug 1, 2022

    Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,

    Active, not recruiting
    • Bilateral Breast Carcinoma
    • +11 more
    • Scottsdale, Arizona
    • +11 more
    Jan 12, 2023

    Folate Deficiency, Vitamin B 12 Deficiency, Anemia, Megaloblastic Trial in Arba Minch (Folic acid and vitamin B12 fortified

    Not yet recruiting
    • Folate Deficiency
    • +4 more
    • Folic acid and vitamin B12 fortified flour
    • Unfortified cereal flour
    • Arba Minch, Ethiopia
      Arba Minch University
    Oct 20, 2023

    Healthy Mums, Healthy Babies: Multiple Micronutrient

    Not yet recruiting
    • Birth Weight
    • Multiple micronutrient supplementation (MMS)
    • Iron folate supplementation (IFA)
    • Addis Ababa, Ethiopia
      Ethiopia Public Health Institute
    Jan 23, 2023

    Periconceptional Surveillance in India

    Active, not recruiting
    • Anemia
    • +2 more
      • Madanapalle, Andhra Pradesh, India
        Arogyavaram Medical Centre
      Jun 3, 2022